Tamoxifen use and potential effects on liver parenchyma: A long‐term prospective transient elastographic evaluation
Abstract Tamoxifen is a commonly prescribed drug in both early and metastatic breast cancer. Prospective studies in Asian populations demonstrated that tamoxifen‐related liver steatosis occurred in more than 30% of the patients within 2 years after start of treatment. No well‐designed prospective st...
Main Authors: | C. Louwrens Braal, Robert J. deKnegt, Agnes Jager, Stijn L. W. Koolen, Ron H. J. Mathijssen, Karel Eechoute |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Health/LWW
2022-09-01
|
Series: | Hepatology Communications |
Online Access: | https://doi.org/10.1002/hep4.2008 |
Similar Items
-
Health-related quality of life and productivity costs in breast cancer patients treated with tamoxifen in the Netherlands
by: Anne Kleijburg, et al.
Published: (2023-02-01) -
Influence of probenecid on endoxifen systemic exposure in breast cancer patients on adjuvant tamoxifen treatment
by: Stefan A. J. Buck, et al.
Published: (2022-03-01) -
CBD-oil as a potential solution in case of severe tamoxifen-related side effects
by: Sanne M. Buijs, et al.
Published: (2023-08-01) -
Toward model-informed precision dosing for tamoxifen: A population-pharmacokinetic model with a continuous CYP2D6 activity scale
by: Bram C. Agema, et al.
Published: (2023-04-01) -
Integrated Data Analysis of Six Clinical Studies Points Toward Model-Informed Precision Dosing of Tamoxifen
by: Lena Klopp-Schulze, et al.
Published: (2020-03-01)